Paul I Terasaki
Overview
Explore the profile of Paul I Terasaki including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
122
Citations
2105
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Taniguchi M, Rebellato L, Briley K, Haisch C, Bolin P, Banuelos N, et al.
Clin Transpl
. 2017 May;
31:293-301.
PMID: 28514591
Background: Human leukocyte antigen (HLA) antibodies are a major cause of graft loss in mismatched transplant recipients. However, the time to graft loss resulting from antibody induced injury is unpredictable....
2.
Ravindranath M, Jucaud V, Banuelos N, Everly M, Cai J, Nguyen A, et al.
J Immunol
. 2017 May;
198(11):4524-4538.
PMID: 28476933
Luminex multiplex immunoassays enable simultaneous monitoring of Abs against multiple Ags in autoimmune, inflammatory, and infectious diseases. The assays are used extensively to monitor anti-HLA Abs in transplant patients for...
3.
Jucaud V, Ravindranath M, Terasaki P
Transplantation
. 2016 Aug;
101(4):764-777.
PMID: 27495776
Background: Single antigen beads (SAB) are used for monitoring HLA antibodies in pretransplant and posttransplant patients despite the discrepancy between virtual and actual crossmatch results and transplant outcomes. This discrepancy...
4.
Prevalence and Clinical Impact of Donor-Specific Alloantibody Among Intestinal Transplant Recipients
Cheng E, Everly M, Kaneku H, Banuelos N, Wozniak L, Venick R, et al.
Transplantation
. 2016 Aug;
101(4):873-882.
PMID: 27490417
Background: Rejection remains the leading cause of allograft loss, and a major barrier to improving long-term outcomes after intestinal transplantation. Our aim is to define the prevalence and investigate the...
5.
Lachmann N, Schonemann C, El-Awar N, Everly M, Budde K, Terasaki P, et al.
Nephrol Dial Transplant
. 2016 May;
31(8):1351-9.
PMID: 27190369
Background: A considerable proportion of patients awaiting kidney transplantation is immunized by previous transplantation(s). We investigated how allograft nephrectomy (Nx) and withdrawal of maintenance immunosuppression (WD-MIS) in patients with a...
6.
Ravindranath M, Jucaud V, Maehara C, Terasaki P
Immunol Lett
. 2016 Jan;
170:68-79.
PMID: 26721232
The presence of IgG against pathogens in the cord blood (CB) of vaccinated mothers is attributed to transplacental transfer. However, previous studies using lymphocytotoxicity assay showed anti-HLA IgG in mother's...
7.
Cai J, Terasaki P, Zhu D, Lachmann N, Schonemann C, Everly M, et al.
Exp Mol Pathol
. 2015 Dec;
100(1):45-50.
PMID: 26615783
Background: We have found antibodies against denatured HLA class I antigens in the serum of allograft recipients which were not significantly associated with graft failure. It is unknown whether transplant...
8.
Rebellato L, Parker K, Everly M, Briley K, Kendrick W, Kendrick S, et al.
Clin Transpl
. 2015 Aug;
:137-42.
PMID: 26281138
The development of donor specific antibodies (DSA) post transplant has been associated with chronic rejection and graft failure. In a longitudinal study, we have shown that increases in DSA precede...
9.
Ravindranath M, Terasaki P, Pham T, Jucaud V
Monoclon Antib Immunodiagn Immunother
. 2015 Jun;
34(3):135-53.
PMID: 26090591
In human cancers, over-expression of HLA-E is marked by gene expression. However, immunolocalization of HLA-E on tumor cells is impeded by the HLA-Ia reactivity of commercial anti-HLA-E monoclonal antibodies (MAbs)....
10.
Zhu H, He J, Cai J, Yuan X, Jiang H, Luo C, et al.
Clin Transplant
. 2014 Aug;
28(11):1225-33.
PMID: 25123053
Graft failure and survival are the major problems for patients with aplastic anemia undergoing hematopoietic stem cell transplantation (HSCT). Previous studies showed that anti-HLA antibodies negatively impact engraftment in HSCT....